U.S. markets open in 1 hour 22 minutes

  • S&P Futures

    4,227.50
    +17.50 (+0.42%)
     

  • Dow Futures

    33,419.00
    +159.00 (+0.48%)
     

  • Nasdaq Futures

    13,447.25
    +55.25 (+0.41%)
     

  • Russell 2000 Futures

    1,980.20
    +10.70 (+0.54%)
     

  • Crude Oil

    92.96
    +1.03 (+1.12%)
     

  • Gold

    1,809.90
    -3.80 (-0.21%)
     

  • Silver

    20.57
    -0.18 (-0.85%)
     

  • EUR/USD

    1.0331
    +0.0029 (+0.28%)
     

  • 10-Yr Bond

    2.7860
    0.0000 (0.00%)
     

  • Vix

    19.79
    -1.98 (-9.10%)
     

  • GBP/USD

    1.2214
    -0.0004 (-0.03%)
     

  • USD/JPY

    132.2330
    -0.6400 (-0.48%)
     

  • BTC-USD

    24,598.34
    +1,476.01 (+6.38%)
     

  • CMC Crypto 200

    580.01
    +48.79 (+9.19%)
     

  • FTSE 100

    7,481.43
    -25.68 (-0.34%)
     

  • Nikkei 225

    27,819.33
    -180.63 (-0.65%)
     

Officer goes beyond duty to help family with 2 young girls

Officer Foster decided to go to McDonald’s and get the family some dinner and she noticed it seemed like they hadn’t eaten in a while.

Recommended Stories

  • Avaya Taps Legal, Financial Advisers to Look at Debt Options

    Avaya Holdings is working with legal and financial advisers to evaluate the company’s options following an earnings miss that tanked prices of a $600 million debt deal completed in June, according to people familiar with the matter. Avaya is being advised by law firm Kirkland & Ellis LLP and turnaround adviser AlixPartners LLP as the company contends with blowback from credit markets, these people said. The cloud-communications company said on Tuesday that there is substantial doubt on its ability to continue as a going concern in light of a debt maturity next year and third-quarter revenues that came in “substantially lower” than Avaya expected.

  • Avaya Holdings Corp. (AVYA) Q3 2022 Earnings Call Transcript

    Welcome to Avaya's call to discuss certain preliminary fiscal 2022 third quarter financial results. Alan Masarek, Avaya's president and CEO; and Kieran McGrath, executive vice president and CFO, will lead this video conference and share with you some prepared remarks. Also during this call, we will be making certain forward-looking statements, including statements concerning our future prospects; financial results; liquidity; cost-cutting initiatives; internal controls; ongoing investigations by our Audit Committee; our strategies, investments; industry trends; and our ability to successfully respond to business risks, including those related to the spread of COVID-19, inflation and increased raw materials costs and other supply chain issues.

  • These Analysts Just Made An Downgrade To Their Novavax, Inc. (NASDAQ:NVAX) EPS Forecasts

    The latest analyst coverage could presage a bad day for Novavax, Inc. ( NASDAQ:NVAX ), with the analysts making...

  • ‘Load Up,’ Says Jim Cramer About These 2 ‘Strong Buy’ Stocks

    The last few years saw the markets go crazy. Between the COVID lockdowns and market crash, the rebound recovery, last year’s sustained bull run, and this year’s devastating first half that saw the bull turn into a bear. But in all of that, there have been stocks that have outperformed the market. These winning stocks have attracted attention from Jim Cramer, the well-known host of CNBC’s ‘Mad Money’ program. Among other things, Cramer has been following stocks which won big during the COVID cris

  • GSK Confirms Rotavirus Vaccine Shortage, Hits Four African Countries: Report

    After disruptions at GSK plc (NYSE: GSK), supplies of rotavirus infection vaccine in children have either run out in Kenya, Tanzania, Senegal, and Cameroon or are close, Reuters reported citing officials close to the roll-out. According to the World Health Organization, up to 200,000 children die each year of contagious infection. The infection causes severe, dehydrating gastroenteritis in children under five years. GSK confirmed a shortfall of around 4 million doses of its Rotarix vaccine in 20

  • NIO: Mounting Headwinds Batter Investor Confidence

    Persistent supply issues have deflated expectations for the Chinese automaker

  • Looking for Dividend Aristocrat Bargains? Here Are 2 Names That Analysts Like the Most

    Investors like getting a return on investment, of course, it’s why they are in the market to begin with. And when a company makes a commitment to return capital and profits to the shareholders, that’s a win – one that will both attract and reward investors. The key for investors is to find the best possible capital return, and dividend stocks make a logical place to start looking. With this in mind, we’ve used the TipRanks database to pull up the details on two true dividend aristocrats – real c

  • 3 Top Tech Stocks to Buy During a Recession

    Choosing stocks that can weather the storm and do well afterward, too, are the kinds of companies we should seek out, and the following trio of top tech stocks should outperform no matter what the market throws at it. Having shed its Warner Media division into the newly reconstituted Warner Bros Discovery in April, AT&T (NYSE: T) is now able to focus solely on its telecom operations and the rollout of its 5G network that will provide the industry with its next wave of growth. Although AT&T says it's not immune from the recessionary impacts affecting the broader economy, it's capable of managing through them and investing for the long-term benefit of customers and investors.

  • 2 Stock-Split Stocks That Have Never Been Cheaper and 1 Value Trap to Avoid Like the Plague

    Among the dozens of stocks to enact splits this year are two industry leaders that scream value and one cash-rich company that's clobbering its shareholders.

  • Sanofi and GSK Sink as Zantac Worries Wipe Out $40 Billion

    (Bloomberg) -- Sanofi, GSK Plc and Haleon Plc extended their declines and have lost a combined $40 billion in market value since Tuesday’s close amid mounting concerns about litigations around recalled heartburn drug Zantac.Most Read from BloombergMusk Sells Another $6.9 Billion of Tesla Ahead of Twitter TrialDozens in China Infected With New ‘Langya’ Virus Carried by ShrewsMedia Counts Differ With 11 Million Votes Collated: Kenya UpdateUS Inflation Runs Cooler Than Forecast, Easing Pressure on

  • 2 Tech Stocks You Can Buy and Hold for the Next Decade

    Technology stocks have been among the best-performing sectors over the past month, second only to consumer discretionary stocks. Admittedly, the tech-laden Nasdaq 100 index is still down 19% in 2022, compared to a 13% decline in the S&P 500 and a 9% drop in the Dow Jones Industrial Average, but the rally indicates the sector is not dead. Tech stocks carried the market on its nearly decade-and-a-half bull run before they were frozen out at the end of last year as traders switched to seemingly more recession-resistant names.

  • 3 Reasons to Buy the Dip on Palantir

    The mercurial stock is down after earnings, but there is still plenty of reason for optimism for long-term investors.

  • Social Security Benefits Are Projected to Increase. Here’s How Much.

    The Senior Citizens League projects the annual cost-of-living adjustment for 2023 to come in at 9.6%, down slightly from the prior month's estimate as inflation cooled a bit.

  • Should I sell my house now before prices crash — or wait for the next big real estate boom?

    The housing market is changing fast. Act accordingly.

  • Stocks moving in after hours: Disney, Bumble, Sonos

    Yahoo Finance Live anchor Akiko Fujita examines several trending stocks making moves in after hours trading.

  • Four REITS That Pay Monthly Dividends

    One of the big advantages of owning certain real estate investment trusts (REITs) over common stock is this: Some pay dividends monthly. Stocks pay dividends quarterly, which is nice, but monthly sounds better to more than a few investors. With that in mind, here are five REITs paying the monthly dividends. 1. Agree Realty Corp. (NYSE: ADC) pays a 3.61% annualized dividend and trades on the New York Stock Exchange with an average daily volume of 815,000 shares. The monthly dividend payment is $0

  • FCC denies SpaceX's Starlink its $1 billion bid on rural broadband expansion

    Yahoo Finance Live's Rachelle Akuffo reports on the FCC rebuffing SpaceX's bid for rural broadband subsidies.

  • Oregon biotech Siga Technologies set to deliver first monkeypox treatment

    Four years after Siga Technologies (Nasdaq: SIGA) gained approval for a smallpox drug, the Corvallis company is gearing up to get the same antiviral into a clinical trial for monkeypox. Tpoxx, also known as tecovirimat, is the only drug available to treat the virus, though it is not yet approved in the U.S. for the disease. The Food and Drug Administration designated Tpoxx as an investigational drug for monkeypox, allowing it to be released from the Strategic National Stockpile only after prescribers jump through considerable hoops.

  • Coupang, Inc. (CPNG) Reports Q2 Loss, Misses Revenue Estimates

    Coupang, Inc. (CPNG) delivered earnings and revenue surprises of 63.64% and 2.24%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

  • 3 Supercharged Growth Stocks Down 88% to 93% That Billionaires Can't Stop Buying

    Not even a bear market decline can faze billionaire money managers who are intent on owning innovative companies and future industry leaders.